Global Rare Disease Drug Sales Market Report 2018

January 2018 | 127 pages | ID: GACEEB89807EN
QYResearch

Abstracts

In this report, the global Rare Disease Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Doses), revenue (Million USD), market share and growth rate of Rare Disease Drug for these regions, from 2013 to 2025 (forecast), covering

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Global Rare Disease Drug market competition by top manufacturers/players, with Rare Disease Drug sales volume, Price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis AG
• Bristol-Myers Squibb Company
• Celgene Corporation
• F. Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• Sanofi S.A.
• Alexion Pharmaceuticals, Inc.
• Eli Lilly and Company
• Novo Nordisk A/S
• AstraZeneca
• Eisai Co., Ltd.
• Daiichi Sankyo Company Limited
• Bayer AG
• GlaxoSmithKline
• Merck & Co., Inc.
• Johnson & Johnson
• Biogen, Inc.
• Shire
• Amgen, Inc.
• Deciphera
• Atara Biotherapeutics
• ProQR

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• >1‰
• 0.65‰～1‰
• <0.1‰

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital Pharmacies
• Speciality Pharmacies
• Retail pharmacies
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Rare Disease Drug Sales Market Report 2018

1 RARE DISEASE DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Rare Disease Drug
1.2 Classification of Rare Disease Drug by Product Category
  1.2.1 Global Rare Disease Drug Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 Global Rare Disease Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 >1‰
  1.2.4 0.65‰～1‰
  1.2.5 <0.1‰
1.3 Global Rare Disease Drug Market by Application/End Users
  1.3.1 Global Rare Disease Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital Pharmacies
  1.3.3 Speciality Pharmacies
  1.3.4 Retail pharmacies
  1.3.5 Others
1.4 Global Rare Disease Drug Market by Region
  1.4.1 Global Rare Disease Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 United States Rare Disease Drug Status and Prospect (2013-2025)
  1.4.3 China Rare Disease Drug Status and Prospect (2013-2025)
  1.4.4 Europe Rare Disease Drug Status and Prospect (2013-2025)
  1.4.5 Japan Rare Disease Drug Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Rare Disease Drug Status and Prospect (2013-2025)
  1.4.7 India Rare Disease Drug Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Rare Disease Drug (2013-2025)
  1.5.1 Global Rare Disease Drug Sales and Growth Rate (2013-2025)
  1.5.2 Global Rare Disease Drug Revenue and Growth Rate (2013-2025)

2 GLOBAL RARE DISEASE DRUG COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Rare Disease Drug Market Competition by Players/Suppliers
  2.1.1 Global Rare Disease Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Global Rare Disease Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Rare Disease Drug (Volume and Value) by Type
  2.2.1 Global Rare Disease Drug Sales and Market Share by Type (2013-2018)
  2.2.2 Global Rare Disease Drug Revenue and Market Share by Type (2013-2018)
2.3 Global Rare Disease Drug (Volume and Value) by Region
  2.3.1 Global Rare Disease Drug Sales and Market Share by Region (2013-2018)
  2.3.2 Global Rare Disease Drug Revenue and Market Share by Region (2013-2018)
2.4 Global Rare Disease Drug (Volume) by Application

3 UNITED STATES RARE DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 United States Rare Disease Drug Sales and Value (2013-2018)
  3.1.1 United States Rare Disease Drug Sales and Growth Rate (2013-2018)
  3.1.2 United States Rare Disease Drug Revenue and Growth Rate (2013-2018)
  3.1.3 United States Rare Disease Drug Sales Price Trend (2013-2018)
3.2 United States Rare Disease Drug Sales Volume and Market Share by Players (2013-2018)
3.3 United States Rare Disease Drug Sales Volume and Market Share by Type (2013-2018)
3.4 United States Rare Disease Drug Sales Volume and Market Share by Application (2013-2018)

4 CHINA RARE DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 China Rare Disease Drug Sales and Value (2013-2018)
  4.1.1 China Rare Disease Drug Sales and Growth Rate (2013-2018)
  4.1.2 China Rare Disease Drug Revenue and Growth Rate (2013-2018)
  4.1.3 China Rare Disease Drug Sales Price Trend (2013-2018)
4.2 China Rare Disease Drug Sales Volume and Market Share by Players (2013-2018)
4.3 China Rare Disease Drug Sales Volume and Market Share by Type (2013-2018)
4.4 China Rare Disease Drug Sales Volume and Market Share by Application (2013-2018)

5 EUROPE RARE DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Rare Disease Drug Sales and Value (2013-2018)
  5.1.1 Europe Rare Disease Drug Sales and Growth Rate (2013-2018)
  5.1.2 Europe Rare Disease Drug Revenue and Growth Rate (2013-2018)
  5.1.3 Europe Rare Disease Drug Sales Price Trend (2013-2018)
5.2 Europe Rare Disease Drug Sales Volume and Market Share by Players (2013-2018)
5.3 Europe Rare Disease Drug Sales Volume and Market Share by Type (2013-2018)
5.4 Europe Rare Disease Drug Sales Volume and Market Share by Application (2013-2018)

6 JAPAN RARE DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Rare Disease Drug Sales and Value (2013-2018)
  6.1.1 Japan Rare Disease Drug Sales and Growth Rate (2013-2018)
  6.1.2 Japan Rare Disease Drug Revenue and Growth Rate (2013-2018)
  6.1.3 Japan Rare Disease Drug Sales Price Trend (2013-2018)
6.2 Japan Rare Disease Drug Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Rare Disease Drug Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Rare Disease Drug Sales Volume and Market Share by Application (2013-2018)

7 SOUTHEAST ASIA RARE DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Rare Disease Drug Sales and Value (2013-2018)
  7.1.1 Southeast Asia Rare Disease Drug Sales and Growth Rate (2013-2018)
  7.1.2 Southeast Asia Rare Disease Drug Revenue and Growth Rate (2013-2018)
  7.1.3 Southeast Asia Rare Disease Drug Sales Price Trend (2013-2018)
7.2 Southeast Asia Rare Disease Drug Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Rare Disease Drug Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Rare Disease Drug Sales Volume and Market Share by Application (2013-2018)

8 INDIA RARE DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 India Rare Disease Drug Sales and Value (2013-2018)
  8.1.1 India Rare Disease Drug Sales and Growth Rate (2013-2018)
  8.1.2 India Rare Disease Drug Revenue and Growth Rate (2013-2018)
  8.1.3 India Rare Disease Drug Sales Price Trend (2013-2018)
8.2 India Rare Disease Drug Sales Volume and Market Share by Players (2013-2018)
8.3 India Rare Disease Drug Sales Volume and Market Share by Type (2013-2018)
8.4 India Rare Disease Drug Sales Volume and Market Share by Application (2013-2018)

9 GLOBAL RARE DISEASE DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Novartis AG
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Rare Disease Drug Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Novartis AG Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.1.4 Main Business/Business Overview
9.2 Bristol-Myers Squibb Company
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Rare Disease Drug Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Bristol-Myers Squibb Company Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.2.4 Main Business/Business Overview
9.3 Celgene Corporation
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Rare Disease Drug Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Celgene Corporation Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.3.4 Main Business/Business Overview
9.4 F. Hoffmann-La Roche Ltd.
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Rare Disease Drug Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.4.4 Main Business/Business Overview
9.5 Pfizer, Inc.
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Rare Disease Drug Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Pfizer, Inc. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.5.4 Main Business/Business Overview
9.6 Sanofi S.A.
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Rare Disease Drug Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Sanofi S.A. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.6.4 Main Business/Business Overview
9.7 Alexion Pharmaceuticals, Inc.
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Rare Disease Drug Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.7.4 Main Business/Business Overview
9.8 Eli Lilly and Company
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Rare Disease Drug Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Eli Lilly and Company Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.8.4 Main Business/Business Overview
9.9 Novo Nordisk A/S
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Rare Disease Drug Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Novo Nordisk A/S Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.9.4 Main Business/Business Overview
9.10 AstraZeneca
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Rare Disease Drug Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 AstraZeneca Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.10.4 Main Business/Business Overview
9.11 Eisai Co., Ltd.
9.12 Daiichi Sankyo Company Limited
9.13 Bayer AG
9.14 GlaxoSmithKline
9.15 Merck & Co., Inc.
9.16 Johnson & Johnson
9.17 Biogen, Inc.
9.18 Shire
9.19 Amgen, Inc.
9.20 Deciphera
9.21 Atara Biotherapeutics
9.22 ProQR

10 RARE DISEASE DRUG MAUFACTURING COST ANALYSIS

10.1 Rare Disease Drug Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Rare Disease Drug
10.3 Manufacturing Process Analysis of Rare Disease Drug

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Rare Disease Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Rare Disease Drug Major Manufacturers in 2017
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL RARE DISEASE DRUG MARKET FORECAST (2018-2025)

14.1 Global Rare Disease Drug Sales Volume, Revenue and Price Forecast (2018-2025)
  14.1.1 Global Rare Disease Drug Sales Volume and Growth Rate Forecast (2018-2025)
  14.1.2 Global Rare Disease Drug Revenue and Growth Rate Forecast (2018-2025)
  14.1.3 Global Rare Disease Drug Price and Trend Forecast (2018-2025)
14.2 Global Rare Disease Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  14.2.1 Global Rare Disease Drug Sales Volume and Growth Rate Forecast by Regions (2018-2025)
  14.2.2 Global Rare Disease Drug Revenue and Growth Rate Forecast by Regions (2018-2025)
  14.2.3 United States Rare Disease Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.4 China Rare Disease Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.5 Europe Rare Disease Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.6 Japan Rare Disease Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.7 Southeast Asia Rare Disease Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.8 India Rare Disease Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Rare Disease Drug Sales Volume, Revenue and Price Forecast by Type (2018-2025)
  14.3.1 Global Rare Disease Drug Sales Forecast by Type (2018-2025)
  14.3.2 Global Rare Disease Drug Revenue Forecast by Type (2018-2025)
  14.3.3 Global Rare Disease Drug Price Forecast by Type (2018-2025)
14.4 Global Rare Disease Drug Sales Volume Forecast by Application (2018-2025)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Rare Disease Drug
Figure Global Rare Disease Drug Sales Volume Comparison (K Doses) by Type (2013-2025)
Figure Global Rare Disease Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure >1‰ Product Picture
Figure 0.65‰～1‰ Product Picture
Figure <0.1‰ Product Picture
Figure Global Rare Disease Drug Sales Comparison (K Doses) by Application (2013-2025)
Figure Global Sales Market Share of Rare Disease Drug by Application in 2017
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Speciality Pharmacies Examples
Table Key Downstream Customer in Speciality Pharmacies
Figure Retail pharmacies Examples
Table Key Downstream Customer in Retail pharmacies
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Rare Disease Drug Market Size (Million USD) by Regions (2013-2025)
Figure United States Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Rare Disease Drug Sales Volume (K Doses) and Growth Rate (2013-2025)
Figure Global Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Rare Disease Drug Sales Volume (K Doses) (2013-2018)
Table Global Rare Disease Drug Sales (K Doses) of Key Players/Suppliers (2013-2018)
Table Global Rare Disease Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Rare Disease Drug Sales Share by Players/Suppliers
Figure 2017 Rare Disease Drug Sales Share by Players/Suppliers
Figure Global Rare Disease Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Rare Disease Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Rare Disease Drug Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Rare Disease Drug Revenue Share by Players
Table 2017 Global Rare Disease Drug Revenue Share by Players
Table Global Rare Disease Drug Sales (K Doses) and Market Share by Type (2013-2018)
Table Global Rare Disease Drug Sales Share (K Doses) by Type (2013-2018)
Figure Sales Market Share of Rare Disease Drug by Type (2013-2018)
Figure Global Rare Disease Drug Sales Growth Rate by Type (2013-2018)
Table Global Rare Disease Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Rare Disease Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Rare Disease Drug by Type (2013-2018)
Figure Global Rare Disease Drug Revenue Growth Rate by Type (2013-2018)
Table Global Rare Disease Drug Sales Volume (K Doses) and Market Share by Region (2013-2018)
Table Global Rare Disease Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Rare Disease Drug by Region (2013-2018)
Figure Global Rare Disease Drug Sales Growth Rate by Region in 2017
Table Global Rare Disease Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Rare Disease Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Rare Disease Drug by Region (2013-2018)
Figure Global Rare Disease Drug Revenue Growth Rate by Region in 2017
Table Global Rare Disease Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Rare Disease Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Rare Disease Drug by Region (2013-2018)
Figure Global Rare Disease Drug Revenue Market Share by Region in 2017
Table Global Rare Disease Drug Sales Volume (K Doses) and Market Share by Application (2013-2018)
Table Global Rare Disease Drug Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Rare Disease Drug by Application (2013-2018)
Figure Global Rare Disease Drug Sales Market Share by Application (2013-2018)
Figure United States Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure United States Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Rare Disease Drug Sales Price (USD/Dose) Trend (2013-2018)
Table United States Rare Disease Drug Sales Volume (K Doses) by Players (2013-2018)
Table United States Rare Disease Drug Sales Volume Market Share by Players (2013-2018)
Figure United States Rare Disease Drug Sales Volume Market Share by Players in 2017
Table United States Rare Disease Drug Sales Volume (K Doses) by Type (2013-2018)
Table United States Rare Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure United States Rare Disease Drug Sales Volume Market Share by Type in 2017
Table United States Rare Disease Drug Sales Volume (K Doses) by Application (2013-2018)
Table United States Rare Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure United States Rare Disease Drug Sales Volume Market Share by Application in 2017
Figure China Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure China Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Rare Disease Drug Sales Price (USD/Dose) Trend (2013-2018)
Table China Rare Disease Drug Sales Volume (K Doses) by Players (2013-2018)
Table China Rare Disease Drug Sales Volume Market Share by Players (2013-2018)
Figure China Rare Disease Drug Sales Volume Market Share by Players in 2017
Table China Rare Disease Drug Sales Volume (K Doses) by Type (2013-2018)
Table China Rare Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure China Rare Disease Drug Sales Volume Market Share by Type in 2017
Table China Rare Disease Drug Sales Volume (K Doses) by Application (2013-2018)
Table China Rare Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure China Rare Disease Drug Sales Volume Market Share by Application in 2017
Figure Europe Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Europe Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Rare Disease Drug Sales Price (USD/Dose) Trend (2013-2018)
Table Europe Rare Disease Drug Sales Volume (K Doses) by Players (2013-2018)
Table Europe Rare Disease Drug Sales Volume Market Share by Players (2013-2018)
Figure Europe Rare Disease Drug Sales Volume Market Share by Players in 2017
Table Europe Rare Disease Drug Sales Volume (K Doses) by Type (2013-2018)
Table Europe Rare Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure Europe Rare Disease Drug Sales Volume Market Share by Type in 2017
Table Europe Rare Disease Drug Sales Volume (K Doses) by Application (2013-2018)
Table Europe Rare Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure Europe Rare Disease Drug Sales Volume Market Share by Application in 2017
Figure Japan Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Japan Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Rare Disease Drug Sales Price (USD/Dose) Trend (2013-2018)
Table Japan Rare Disease Drug Sales Volume (K Doses) by Players (2013-2018)
Table Japan Rare Disease Drug Sales Volume Market Share by Players (2013-2018)
Figure Japan Rare Disease Drug Sales Volume Market Share by Players in 2017
Table Japan Rare Disease Drug Sales Volume (K Doses) by Type (2013-2018)
Table Japan Rare Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Rare Disease Drug Sales Volume Market Share by Type in 2017
Table Japan Rare Disease Drug Sales Volume (K Doses) by Application (2013-2018)
Table Japan Rare Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Rare Disease Drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Southeast Asia Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Rare Disease Drug Sales Price (USD/Dose) Trend (2013-2018)
Table Southeast Asia Rare Disease Drug Sales Volume (K Doses) by Players (2013-2018)
Table Southeast Asia Rare Disease Drug Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Rare Disease Drug Sales Volume Market Share by Players in 2017
Table Southeast Asia Rare Disease Drug Sales Volume (K Doses) by Type (2013-2018)
Table Southeast Asia Rare Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Rare Disease Drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Rare Disease Drug Sales Volume (K Doses) by Application (2013-2018)
Table Southeast Asia Rare Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Rare Disease Drug Sales Volume Market Share by Application in 2017
Figure India Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure India Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Rare Disease Drug Sales Price (USD/Dose) Trend (2013-2018)
Table India Rare Disease Drug Sales Volume (K Doses) by Players (2013-2018)
Table India Rare Disease Drug Sales Volume Market Share by Players (2013-2018)
Figure India Rare Disease Drug Sales Volume Market Share by Players in 2017
Table India Rare Disease Drug Sales Volume (K Doses) by Type (2013-2018)
Table India Rare Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure India Rare Disease Drug Sales Volume Market Share by Type in 2017
Table India Rare Disease Drug Sales Volume (K Doses) by Application (2013-2018)
Table India Rare Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure India Rare Disease Drug Sales Volume Market Share by Application in 2017
Table Novartis AG Basic Information List
Table Novartis AG Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Novartis AG Rare Disease Drug Sales Growth Rate (2013-2018)
Figure Novartis AG Rare Disease Drug Sales Global Market Share (2013-2018)
Figure Novartis AG Rare Disease Drug Revenue Global Market Share (2013-2018)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Company Rare Disease Drug Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Company Rare Disease Drug Sales Global Market Share (2013-2018)
Figure Bristol-Myers Squibb Company Rare Disease Drug Revenue Global Market Share (2013-2018)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Celgene Corporation Rare Disease Drug Sales Growth Rate (2013-2018)
Figure Celgene Corporation Rare Disease Drug Sales Global Market Share (2013-2018
Figure Celgene Corporation Rare Disease Drug Revenue Global Market Share (2013-2018)
Table F. Hoffmann-La Roche Ltd. Basic Information List
Table F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales Global Market Share (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Rare Disease Drug Revenue Global Market Share (2013-2018)
Table Pfizer, Inc. Basic Information List
Table Pfizer, Inc. Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Pfizer, Inc. Rare Disease Drug Sales Growth Rate (2013-2018)
Figure Pfizer, Inc. Rare Disease Drug Sales Global Market Share (2013-2018)
Figure Pfizer, Inc. Rare Disease Drug Revenue Global Market Share (2013-2018)
Table Sanofi S.A. Basic Information List
Table Sanofi S.A. Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sanofi S.A. Rare Disease Drug Sales Growth Rate (2013-2018)
Figure Sanofi S.A. Rare Disease Drug Sales Global Market Share (2013-2018
Figure Sanofi S.A. Rare Disease Drug Revenue Global Market Share (2013-2018)
Table Alexion Pharmaceuticals, Inc. Basic Information List
Table Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales Growth Rate (2013-2018)
Figure Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales Global Market Share (2013-2018)
Figure Alexion Pharmaceuticals, Inc. Rare Disease Drug Revenue Global Market Share (2013-2018)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Rare Disease Drug Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company Rare Disease Drug Sales Global Market Share (2013-2018
Figure Eli Lilly and Company Rare Disease Drug Revenue Global Market Share (2013-2018)
Table Novo Nordisk A/S Basic Information List
Table Novo Nordisk A/S Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Novo Nordisk A/S Rare Disease Drug Sales Growth Rate (2013-2018)
Figure Novo Nordisk A/S Rare Disease Drug Sales Global Market Share (2013-2018)
Figure Novo Nordisk A/S Rare Disease Drug Revenue Global Market Share (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure AstraZeneca Rare Disease Drug Sales Growth Rate (2013-2018)
Figure AstraZeneca Rare Disease Drug Sales Global Market Share (2013-2018)
Figure AstraZeneca Rare Disease Drug Revenue Global Market Share (2013-2018)
Table Eisai Co., Ltd. Basic Information List
Table Daiichi Sankyo Company Limited Basic Information List
Table Bayer AG Basic Information List
Table GlaxoSmithKline Basic Information List
Table Merck & Co., Inc. Basic Information List
Table Johnson & Johnson Basic Information List
Table Biogen, Inc. Basic Information List
Table Shire Basic Information List
Table Amgen, Inc. Basic Information List
Table Deciphera Basic Information List
Table Atara Biotherapeutics Basic Information List
Table ProQR Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rare Disease Drug
Figure Manufacturing Process Analysis of Rare Disease Drug
Figure Rare Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Rare Disease Drug Major Players in 2017
Table Major Buyers of Rare Disease Drug
Table Distributors/Traders List
Figure Global Rare Disease Drug Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Global Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Rare Disease Drug Price (USD/Dose) and Trend Forecast (2018-2025)
Table Global Rare Disease Drug Sales Volume (K Doses) Forecast by Regions (2018-2025)
Figure Global Rare Disease Drug Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Rare Disease Drug Sales Volume Market Share Forecast by Regions in 2025
Table Global Rare Disease Drug Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Rare Disease Drug Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Rare Disease Drug Revenue Market Share Forecast by Regions in 2025
Figure United States Rare Disease Drug Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure United States Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Rare Disease Drug Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure China Rare Disease Drug Revenue and Growth Rate Forecast (2018-2025)
Figure Europe Rare Disease Drug Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Europe Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Rare Disease Drug Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Japan Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Rare Disease Drug Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Rare Disease Drug Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure India Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Rare Disease Drug Sales (K Doses) Forecast by Type (2018-2025)
Figure Global Rare Disease Drug Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Rare Disease Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Rare Disease Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Rare Disease Drug Price (USD/Dose) Forecast by Type (2018-2025)
Table Global Rare Disease Drug Sales (K Doses) Forecast by Application (2018-2025)
Figure Global Rare Disease Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources